Congratulations! You now have unlimited access to all articles from The Medicine Maker.
Complete your profile at your earliest convenience to unlock the rest of your benefits:
relevant and personalised updates about your field
access to White Papers/product profiles
digital magazine subscription
The Medicine Maker
Welcome to the May issue! Medical cannabis and scientific research around cannabinoids is booming, but what does this mean for the pharma industry? Read our feature to find out. Meanwhile, Upfront explores the bioactivity of Actinobacteria found within brown seaweed, and how will the industry shape up over the next five years with an infographic. Heather Zenk argues that blockchain could be one solution to the saleable returns verification aspect of the US Drug Supply Chain Security Act, in In My View; and we tell the story of IPEC's humble beginnings with David Schoneker in Best Practice. Finally, we Sit Down With Robert S. Langer, Pediatrics Polymath, Jinling Chen.